Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial. (December 2020)
- Record Type:
- Journal Article
- Title:
- Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial. (December 2020)
- Main Title:
- Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial
- Authors:
- Ryan, Jennifer M
Fortune, Jennifer
Stennett, Andrea
Kilbride, Cherry
Lavelle, Grace
Hendrie, Wendy
DeSouza, Lorraine
Abdul, Mohammed
Brewin, Debbie
David, Lee
Anokye, Nana
Victor, Christina
Norris, Meriel - Abstract:
- Background: There is limited information regarding the safety, feasibility and acceptability of behaviour-change interventions to increase physical activity (PA) and reduce sedentary behaviour among people with multiple sclerosis (MS). Prior to evaluating efficacy, it is important to identify problems with feasibility and acceptability, which may undermine effectiveness. Objective: To examine the safety, feasibility and acceptability of a behaviour-change intervention to increase PA and reduce sedentary behaviour among people with MS. Methods: Sixty people received a 3-month intervention or usual care. Fatigue, pain and adverse events (AEs) were assessed. Feasibility and acceptability were explored through focus groups with physiotherapists and interviews with participants. Fidelity to intervention content, delivery skills, programme receipt and programme task were assessed. Results: There was no difference in AE rate between groups ( p = 0.965). Fatigue and pain were not higher in the intervention group at 3 or 9 months. Therapists reported the intervention was feasible to deliver and fidelity was acceptable. Twenty-nine participants (97%) attended at least 75% of sessions. Participants found the intervention acceptable but suggested some amendments were required to intervention components. Conclusions: The intervention was safe, feasible and acceptable. Although modifications are required to intervention components, the intervention warrants further evaluation in a futureBackground: There is limited information regarding the safety, feasibility and acceptability of behaviour-change interventions to increase physical activity (PA) and reduce sedentary behaviour among people with multiple sclerosis (MS). Prior to evaluating efficacy, it is important to identify problems with feasibility and acceptability, which may undermine effectiveness. Objective: To examine the safety, feasibility and acceptability of a behaviour-change intervention to increase PA and reduce sedentary behaviour among people with MS. Methods: Sixty people received a 3-month intervention or usual care. Fatigue, pain and adverse events (AEs) were assessed. Feasibility and acceptability were explored through focus groups with physiotherapists and interviews with participants. Fidelity to intervention content, delivery skills, programme receipt and programme task were assessed. Results: There was no difference in AE rate between groups ( p = 0.965). Fatigue and pain were not higher in the intervention group at 3 or 9 months. Therapists reported the intervention was feasible to deliver and fidelity was acceptable. Twenty-nine participants (97%) attended at least 75% of sessions. Participants found the intervention acceptable but suggested some amendments were required to intervention components. Conclusions: The intervention was safe, feasible and acceptable. Although modifications are required to intervention components, the intervention warrants further evaluation in a future trial. … (more)
- Is Part Of:
- Multiple sclerosis. Volume 26:Number 14(2020)
- Journal:
- Multiple sclerosis
- Issue:
- Volume 26:Number 14(2020)
- Issue Display:
- Volume 26, Issue 14 (2020)
- Year:
- 2020
- Volume:
- 26
- Issue:
- 14
- Issue Sort Value:
- 2020-0026-0014-0000
- Page Start:
- 1907
- Page End:
- 1918
- Publication Date:
- 2020-12
- Subjects:
- Clinical trial -- fatigue -- multiple sclerosis -- rehabilitation -- pain
Central nervous system -- Diseases -- Periodicals
Myelin sheath -- Diseases -- Periodicals
Inflammation -- Periodicals
Multiple sclerosis -- Periodicals
Central Nervous System Diseases -- Periodicals
Demyelinating Diseases -- Periodicals
Inflammation -- Periodicals
Multiple Sclerosis -- Periodicals
Système nerveux central -- Maladies -- Périodiques
Gaine de myéline -- Maladies -- Périodiques
Inflammation (Pathologie) -- Périodiques
Sclérose en plaques -- Périodiques
Electronic journals
616.834005 - Journal URLs:
- http://msj.sagepub.com/ ↗
http://search.ebscohost.com/login.aspx?direct=true&db=a2h&jid=DZL&site=ehost-live ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1352-4585;screen=info;ECOIP ↗
http://www.arnoldpublishers.com/journals/pages/mul_scl/13524585.htm ↗ - DOI:
- 10.1177/1352458519886231 ↗
- Languages:
- English
- ISSNs:
- 1352-4585
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14479.xml